ScreenerHero
MYGNMyriad Genetics, Inc.
NAS · US · Healthcare · Diagnostics & Research · myriad.com
5.710USD-2.39%Mkt Cap: 539.30M $P/E: —

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides …

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Cheaper
1M Perf
Lower
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap539.30M $
Enterprise Value388.60M $
Revenue (TTM)557.00M $
Gross Profit576.60M $
Net Income (TTM)-365.90M $
Revenue/Share7.452 USD
Last Price5.710 USD
Fiscal Year EndDec 2025
MR QuarterDec 2020
Employees2.7K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS62855J1043
Valuation
P/E (Trailing)—
P/E (Forward)37.79
PEG1.24
EV/EBITDA-3.47
EV/Revenue0.70
P/S0.97
P/B1.60
EPS (TTM)-4.31
EPS (Forward)0.15
52W Range
3.53043% of range8.590
52W High8.590 USD
52W Low3.530 USD
Profitability
Gross Margin69.93%
Oper. Margin-21.41%
EBITDA Margin-20.09%
Profit Margin-44.38%
ROE-99.43%
ROA-51.78%
Growth
Revenue Growth-20.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.80M $
CapEx (TTM)27.40M $
FCF Margin-8.27%
FCF Yield-8.54%
Net Debt-150.70M $
Net Debt/EBITDA1.35
Balance Sheet
Debt/Equity0.57
Current Ratio2.67
Quick Ratio1.65
Book Value/Sh3.574 USD
Cash/Share1.596 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 26, 2009
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.250 USD
Upside (mean)+9.5%
Target Range4.000 USD – 10.00 USD
$4.000+9.5% to mean$10.00
# Analysts8
Ownership
Shares Out.94.45M
Float85.99M
Insiders3.78%
Institutions97.37%
Short Interest
Short Ratio4.9d
Short % Float9.39%
Short % Out.9.16%
Shares Short8.65M
Short (prev mo.)8.33M
Technical
SMA 504.474 (+27.6%)
SMA 2005.817 (-1.8%)
Beta1.64
S&P 52W Chg20.05%
Avg Vol (30d)1.51M
Avg Vol (10d)1.94M
Technical Indicators
RSI (14)70.1
MACD0.3523
MACD Signal0.1954
MACD Hist.+0.1569
BB Upper5.834 USD
BB Middle4.755 USD
BB Lower3.676 USD
BB Width45.38%
ATR (14)0.3228 USD
Vol Ratio (20d)0.97x